Calattini Sara, Fusil Floriane, Mancip Jimmy, Dao Thi Viet Loan, Granier Christelle, Gadot Nicolas, Scoazec Jean-Yves, Zeisel Mirjam B, Baumert Thomas F, Lavillette Dimitri, Dreux Marlène, Cosset François-Loïc
Structure Fédérative de Recherche (SFR) Lyon-Est, ANIPATH-Centre d'Histopathologie du Petit Animal de laboratoire, CNRS UMS3453-INSERM US7, 69372 Lyon, France.
INSERM, U1110, Institut des Maladies Virales et Hépatiques, 67000 Strasbourg, France, University of Strasbourg, 67000 Strasbourg, France, and.
J Biol Chem. 2015 Sep 18;290(38):23173-87. doi: 10.1074/jbc.M115.662999. Epub 2015 Jul 29.
Lipoprotein components are crucial factors for hepatitis C virus (HCV) assembly and entry. As hepatoma cells producing cell culture-derived HCV (HCVcc) particles are impaired in some aspects of lipoprotein metabolism, it is of upmost interest to biochemically and functionally characterize the in vivo produced viral particles, particularly regarding how lipoprotein components modulate HCV entry by lipid transfer receptors such as scavenger receptor BI (SR-BI). Sera from HCVcc-infected liver humanized FRG mice were separated by density gradients. Viral subpopulations, termed HCVfrg particles, were characterized for their physical properties, apolipoprotein association, and infectivity. We demonstrate that, in contrast to the widely spread distribution of apolipoproteins across the different HCVcc subpopulations, the most infectious HCVfrg particles are highly enriched in apoE, suggesting that such apolipoprotein enrichment plays a role for entry of in vivo derived infectious particles likely via usage of apolipoprotein receptors. Consistent with this salient feature, we further reveal previously undefined functionalities of SR-BI in promoting entry of in vivo produced HCV. First, unlike HCVcc, SR-BI is a particularly limiting factor for entry of HCVfrg subpopulations of very low density. Second, HCVfrg entry involves SR-BI lipid transfer activity but not its capacity to bind to the viral glycoprotein E2. In conclusion, we demonstrate that composition and biophysical properties of the different subpopulations of in vivo produced HCVfrg particles modulate their levels of infectivity and receptor usage, hereby featuring divergences with in vitro produced HCVcc particles and highlighting the powerfulness of this in vivo model for the functional study of the interplay between HCV and liver components.
脂蛋白成分是丙型肝炎病毒(HCV)组装和进入的关键因素。由于产生细胞培养衍生的HCV(HCVcc)颗粒的肝癌细胞在脂蛋白代谢的某些方面存在缺陷,因此从生物化学和功能上表征体内产生的病毒颗粒,特别是脂蛋白成分如何通过清道夫受体BI(SR-BI)等脂质转移受体调节HCV进入,具有至关重要的意义。通过密度梯度分离HCVcc感染的肝脏人源化FRG小鼠的血清。对称为HCVfrg颗粒的病毒亚群进行物理性质、载脂蛋白结合和感染性表征。我们证明,与载脂蛋白在不同HCVcc亚群中的广泛分布不同,最具感染性的HCVfrg颗粒高度富含载脂蛋白E,这表明这种载脂蛋白富集可能通过使用载脂蛋白受体在体内衍生的感染性颗粒进入中发挥作用。与这一显著特征一致,我们进一步揭示了SR-BI在促进体内产生的HCV进入方面以前未定义的功能。首先,与HCVcc不同,SR-BI是极低密度HCVfrg亚群进入的一个特别限制因素。其次,HCVfrg进入涉及SR-BI脂质转移活性,而不是其与病毒糖蛋白E2结合 的能力。总之,我们证明体内产生的HCVfrg颗粒不同亚群的组成和生物物理性质调节其感染性水平和受体使用,从而显示出与体外产生的HCVcc颗粒的差异,并突出了这种体内模型在HCV与肝脏成分相互作用功能研究中的强大作用。